Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2017

Jul 28, 2017

5262_dirs_2017-07-28_8d415a67-fc68-4bab-974c-8067b3e00c3f.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4865M

GlaxoSmithKline PLC

28 July 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

1. Details of PDMR/person closely associated with them ('PCA')
a) Name Mrs V A Whyte
b) Position/status SVP & Company Secretary
c) Initial notification/

amendment
Initial Notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GlaxoSmithKline plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882
b) Nature of the transaction A conditional award of Ordinary Shares under the Company's 2017 Performance Share Plan. Vesting of the award is subject to meeting performance criteria over a three year period.
c) Price(s) and

volume(s)
Price(s) Volume(s)
£15.31 12,105
d) Aggregated information n/a (single transaction)
Aggregated volume Price
e) Date of the transaction 2017-07-27
f) Place of the transaction n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEVLFLDDFBBBB